IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
Year: 2006
Type: article
Study design: Observational Study
Abstract: Blood concentrations of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) have recently been associated with breast cancer risk, notably in women who developed breast cancer at a young age. Prospective studies published so far, however, were relatively small and odds ratio (OR) estimates imprecise. We present the results of a large prospective case-control study nested within the European Prospective Investigation into Cancer and Nutrition on total IGF-I, IGFBP-3 and breast cancer risk including 1081 incident cases of invasive breast cancer and 2098 matched control subjects. Increasing IGF-I and IGFBP-3 concentrations were associated with a significant increase in breast cancer risk in women who developed breast cancer after 50 years of age (highest vs lowest quintile OR 1.38 (95% confidence interval (CI) 1.02-1.86), P = 0.01, and 1.44 (95% CI 1.04-1.98), P = 0.01, respectively), but no relationship was observed in younger women (OR = 1.03 (95% CI 0.60-1.77), P = 0.81 for IGF-I, and OR = 0.92 (95% CI 0.50-1.70), P = 0.69 for IGFBP-3). There was, however, significant heterogeneity in the relationship of breast cancer with serum IGF-I and IGFBP-3 levels depending on the time interval between blood donation and tumor diagnosis. A reduction in breast cancer risk with increasing IGF-I concentrations was observed in cases with a diagnosis of cancer less than 2 years after blood donation, (OR = 0.76 (95% CI 0.57-1.03)), while an increase in risk was observed for women with a later diagnosis (above or equal to two years after blood collection, OR = 1.51 (95% CI 1.19-1.91)). A similar pattern was observed for IGFBP-3. This study confirms previous findings for an association of serum IGF-I and IGFBP-3 concentrations with breast cancer risk, particularly for women with a later diagnosis of cancer, but it does not support the hypothesis of an involvement of IGF-I in younger women.
Source: Endocrine Related Cancer
DOI: 10.1677/erc.1.01150
Authors: S Rinaldi, P H M Peeters, F Berrino, L Dossus, C Biessy, A Olsen, A Tjonneland, K Overvad, F Clavel-Chapelon, M C Boutron-Ruault, B Téhard, G Nagel, J Linseisen, H Boeing, P H Lahmann, A Trichopoulou, D Trichopoulos, M Koliva, D Palli, S Panico, R Tumino, C Sacerdote, C H van Gils, P van Noord, D E Grobbee, H B Bueno-de-Mesquita, C A Gonzalez, A Agudo, M D Chirlaque, A Barricarte, N Larrañaga, J R Quiros, S Bingham, K T Khaw, T Key, N E Allen, A Lukanova, N Slimani, R Saracci, E Riboli, R Kaaks
Institutions: Centre international de recherche sur le cancer, University Medical Center Utrecht, Fondazione IRCCS Istituto Nazionale dei Tumori, Danish Cancer Society, Aalborg University Hospital, Aarhus University Hospital, Inserm, Institut Gustave Roussy, German Cancer Research Center, German Institute of Human Nutrition, National and Kapodistrian University of Athens, Federico II University Hospital, University of Naples Federico II, Piedmont Reference Center for Epidemiology and Cancer Prevention, National Institute for Public Health and the Environment, Institut Català d'Oncologia, Instituto de Salud Pública de Navarra, Basque Government, Gobierno del Principado de Asturias, University of Cambridge, Addenbrooke's Hospital, Cancer Research UK, University of Oxford, Cancer Research UK Oxford Centre, New York University, Imperial College London
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Compagnia di San Paolo, Deutsches Krebsforschungszentrum, Wellcome Trust, Cancer Research UK, British Heart Foundation, Stroke Association, European Commission, Institut National de la Santé et de la Recherche Médicale, Bundesministerium für Bildung und Forschung, Cancerfonden, Ligue Contre le Cancer, Deutsche Krebshilfe, Medical Research Council, World Cancer Research Fund, Instituto de Salud Carlos III
OpenAlex ID: W2164373820
